Flu now seeing gains in the Pacific Northwest, Walgreens reports
The Pacific Northwest is now realizing significant flu activity gains according to latest Walgreens Flu Index released Wednesday.
The Seattle and Tacoma, Wash. markets led the nation in flu activity gains for the week ended March 10, according to the report, with Portland, Ore., ranking No. 3. Similarly, the greatest amount of flu activity tracked currently across the Pacific Northwest was found in the Lincoln and Hastings markets in Nebraska while Omaha, Neb., ranked No. 3.
The top 10 designated market areas as measured by flu activity gains for the week ended March 10 were:
The top 10 designated market areas as measured by flu activity for the week ended March 10 were:
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. The Flu Index provides insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.
The Walgreens Flu Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.
The Seattle and Tacoma, Wash. markets led the nation in flu activity gains for the week ended March 10, according to the report, with Portland, Ore., ranking No. 3. Similarly, the greatest amount of flu activity tracked currently across the Pacific Northwest was found in the Lincoln and Hastings markets in Nebraska while Omaha, Neb., ranked No. 3.
The top 10 designated market areas as measured by flu activity gains for the week ended March 10 were:
- Seattle-Tacoma, Wash.;
- Reno, Nev.;
- Portland, Ore.;
- San Diego;
- Albany-Schenectady-Troy, N.Y.;
- Monterey-Salinas, Calif.;
- Sacramento-Stockton-Modesto, Calif.;
- San Francisco-Oakland-San Jose, Calif.;
- Lansing, Mich.; and
- Toledo, Ohio.
The top 10 designated market areas as measured by flu activity for the week ended March 10 were:
- Lincoln & Hastings-Kearney, Neb.;
- Harlingen-Weslaco-Brownsville-McAllen, Texas;
- Omaha, Neb.;
- El Paso, Texas (Las Cruces, N.M.);
- Columbia-Jefferson City, Mo.;
- Oklahoma City;
- Des Moines-Ames, Iowa;
- Corpus Christi, Texas;
- Davenport, Iowa-Rock Island-Moline, Ill.; and
- La Crosse-Eau Claire, Wis.
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. The Flu Index provides insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.
The Walgreens Flu Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.